Clinical Trial Update: A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body [Phase 1]

View source ↗

Summary

Phase 1 study assessing biopharma BI 1467335 processing in people with normal and reduced kidney function; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• BI 1467335 (BI 1467335)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Renal Insufficiency, Healthy | Phase 1 | Status: COMPLETED | Results posted: 2021-06-04